2017 Breast Cancer Abstracts

GCOS2017-P1-001

The spectrum of cardiovascular disease after early stage breast cancer

Presenting Author: Dr. Husam Abdel-Qadir, Graduate Student/Cardiologist, University of Toronto, Toronto, ON, Canada

 

GCOS2017-P1-002

Dynamic changes in high-sensitivity cardiac troponin I concentration in response to anthracycline-based chemotherapy – a pilot study for the Cardiac CARE Randomised Trial

Presenting Author: Dr. Philip Adamson, Clinical Research Fellow, University of Edinburgh, Edinburgh, United Kingdom

 

GCOS2017-P1-003

PRevention Of Anthracycline Cardiovascular Toxicity in patients treated for breast cancer: a phase 3 randomised, open label, blinded endpoint, superiority trial of enalapril to prevent anthracycline-induced cardio-toxicity (PROACT).

Presenting Author: Dr. David Austin, Consultant Cardiologist, South Tees NHS Foundation Trust, Middlesbrough, United Kingdom

 

GCOS2017-P1-004

Assessing the association between hormone therapy use in female breast cancer and subsequent risk of cardiovascular disease: a cohort study in the UK Clinical Practice Research Datalink

Presenting Author: Dr. Krishnan Bhaskaran, Associate Professor, London School of Hygiene and Tropical Medicine, London, United Kingdom

 

GCOS2017-P1-005

Effect of radiotherapy for breast cancer on the prognosis of a subsequent myocardial infarction

Presenting Author: Naomi Boekel, PhD Student, Netherlands Cancer Institute, Amsterdam, Netherlands

 

GCOS2017-P1-006

Strain-guided cardioprotection against trastuzumab-induced cardiotoxicity in patients with her2-positive breast cancer. PRECARD-GLS study.

Presenting Author: Dr. Diego Gimenez Cervantes, Cardiologist, Hospital Morales Mseguer, Murcia, Spain

 

GCOS2017-P1-007

Analysis of use of neo-adjuvant chemotherapy with trastuzumab for patients with HER-2 positive breast cancer

Presenting Author: Dr. Ik Shin Chin, Specialty Registrar, New Cross Hospital Wolverhampton, Birmingham, United Kingdom

 

GCOS2017-P1-008

Adjuvant treatment of Breast cancer related to Cardiotoxicity and Dysfunctional Endothelium. The ABCDE Study

Presenting Author: Mrs. Stine Overvad Fredslund, Medical Doctor/PhD Student, Aarhus University Hospital Brabrand, Denmark

 

GCOS2017-P1-009

Cardiac high-energy phosphates in breast cancer patients during anthracyclines: relationship with ejection fraction and high sensitivity cardiac troponin

Presenting Author: Dr. Olga Oikonomidou, Consultant Medical Oncologist, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, United Kingdom

 

GCOS2017-P1-010

Longitudinal characterisation of cardiac function in recently diagnosed breast cancer patients

Presenting Author: Miss Erifyli Piastopoulou, Trainee, Swansea University, Cardiff, United Kingdom

 

GCOS2017-P1-011

Heart sparing techniques for breast and internal mammary chain radiotherapy

Presenting Author: Dr. Alison Ranger, Clinical Oncology Research Fellow, The Royal Marsden NHS Foundation Trust, Surrey, United Kingdom

 

GCOS2017-P1-012

Adjuvant breast cancer radiotherapy-induced cardiac changes – three-year follow-up results

Presenting Author: Dr. Tanja Skytta, Clinical Oncologist, Tampere University Hospital, Tampere, Finland

 

GCOS2017-P1-013

Rates of trastuzumab-associated cardiotoxicity in HER2-positive breast cancer patients at a tertiary cancer centre

Presenting Author: Dr. Nidhi Kumar Tyagi, Breast Cancer Fellow, McMaster University, Hamilton, ON, Canada

 

GCOS2017-P1-014

Trastuzumab-induced cardiotoxicity – a single centre experience from Estonia

Presenting Author: Dr. Elen Vettus, Oncology Resident, North Estonia Medical Centre, Tallinn, Estonia